SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-14-021876
Filing Date
2014-03-21
Accepted
2014-03-21 17:24:42
Documents
8
Effectiveness Date
2014-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 a14-8440_1s8.htm S-8 105319
2 EX-5.1 a14-8440_1ex5d1.htm EX-5.1 12154
3 EX-23.2 a14-8440_1ex23d2.htm EX-23.2 3702
5 GRAPHIC g84401kgi001.jpg GRAPHIC 1248
6 GRAPHIC g84401kgi002.gif GRAPHIC 8211
7 GRAPHIC g84401gai001.jpg GRAPHIC 1248
8 GRAPHIC g84401gai002.gif GRAPHIC 73
9 GRAPHIC g84401gai003.gif GRAPHIC 8211
  Complete submission text file 0001104659-14-021876.txt   149025
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-194746 | Film No.: 14711233
SIC: 2834 Pharmaceutical Preparations